仲景大小汤辨要

张仲景在《伤寒论》与《金匮要略》中，以大小成对命名方剂者共有六对。其命名的基本条件①凡名同者，其间必有联系；②大汤其药力强，治疗的病情重；小汤其药力弱，治疗的病情轻。理解仲景大小汤的含义，对理解仲景汤方命名规律及临床辨证具有重要意义。     

针刺对实验性脑缺血家兔超微结构的影响

目的：探讨缺血性脑血管病（ＩＣＶＤ）的发病机理,同地结合现代是论为临床针灸治疗缺血提供客观理论依据。方法：运用“三血管”阻断法,以家兔为研究对象,建立了实验性不完全性脑缺血模型,采有“醒脑开窍”针法施以治疗,定性观测大脑皮质超同结构的改变,运用形态学计量法定量观测细胞核和线粒体体密度以及突触间隙。结果：针刺能明显改善脑缺血家兔的大脑皮质超微结构、线粒体、粗面内质网、高 在体破坏程度及核膜凹陷各度明     

Effects of Bojungikgi-tang on anorexic patients with atopic dermatitis: A protocol for a randomized,usual care-controlled,assessor-blinded,parallel, pilot clinical trial

Background:Anorexia and atopic dermatitis (AD) are highly prevalent diseases, and the herbal medicine Bojungikgi-tang (BJT) has been frequently used for the treatment of both anorexia and AD. However, no study has simultaneously evaluated the effects of BJT for both anorexia and AD.Methods:A prospective, randomized, usual care-controlled, assessor-blinded. parallel, pilot clinical trial has been designed to explore the feasibility, preliminary effectiveness, and safety of BJT for the treatment of anorexic patients with AD. Forty anorexic patients with AD will be randomly assigned (1:1) to BJT or the usual care group. The BJT group will be administered BJT granules twice a day for 8 weeks and followed up for 4 weeks whereas the usual care group will not receive BJT granules. All participants in both groups will be provided with over-the-counter topical corticosteroids as a relief drug. Data will be collected at baseline and at 4, 8, and 12 weeks after randomization. The primary outcome is the score on the anorexia visual analog scale at 8 weeks post-treatment. The secondary outcomes include body weight, body fat percentage, body fat mass, skeletal muscle mass, SCORing of Atopic Dermatitis index, Validated Investigator Global Assessment scale for Atopic Dermatitis, Dermatology Life Quality Index, EuroQoL 5 Dimension 5 Level, deficiency and excess pattern identification questionnaire, total immunoglobulin E, eosinophil count, and frequency and amount of use of topical corticosteroids. Adverse events and laboratory test results will be monitored to assess safety. Fecal samples to check for gut microbiome changes and blood samples to check immune and metabolic markers will be collected before and after taking BJT.Discussion:This is the first trial that explores the preliminary effectiveness and safety of BJT for the treatment of anorexic patients with AD. The results of this pilot study will provide the basic evidence for large-scale, confirmatory, multicenter, high-quality clinical trials.Trial registration:Clinical Research Information Service, KCT0006784 (registered on November 26, 2021).     

中追口服药液的抗癌作用实验研究

目的探讨中追口服药液的体内抗肿瘤活性作用效果。方法用小鼠肝癌H22、肉瘤S180模型,观察药物对小鼠瘤块生成的影响。结果中追口服药液对肝癌H22、肉瘤S180有抑制作用。结论中追口服药液具有抗肿瘤作用。     

养精种玉汤对TA系菌株基因回变菌落影响的研究

目的:探讨养精种玉汤对TA97、TA98、TA100、TA102菌株基因回变菌落的影响,对其遗传安全性进行研究。方法:采用直接平皿掺入技术,设养精种玉汤不同剂量对TA97、TA98、TA100、TA102系列菌株进行体外染毒,观察其回复突变菌落增长状况。结果:在0.8~200.0mg/皿的不同测试浓度,+S9与-S9两种测试系统条件下,其作用的4种测试菌株的回变菌落数与溶剂对照相比均无明显增加,回变菌落背景正常,未显示其有抑菌作用,且无剂量-反应关系。结论:养精种玉汤药液在本试验所确定的200.0mg/皿剂量范围内,初步认为对TA系列测试菌株无明显致DNA碱基置换及移码突变性。     

认识领悟疗法治疗对人恐惧症

目的 探讨认识领悟疗法对对人恐惧症的治疗作用.方法 按照钟友彬教授认识领悟疗法的原理、方法和步骤,对来访者实施认识领悟治疗.结果 来访者的恐惧症状在治疗后消失.结论 使用认识领悟疗法治疗对人恐惧症有效.     

“中 气”浅 析

"中气"肇始于《黄帝内经》,后世医家多认为"中气"为中焦脾胃之气,即包含脾气和胃气,又有认为"中气除脾胃之气外,还包含肝胆之气"者。笔者认为,"中气",位居中焦,乃气按分布部位所划分,具有吸收水谷精微、化生气血的功能;主气机之升降出入,有承上启下之功。"中气"斡旋则五脏安和。     

温脾消肿饮治疗特发性水肿的临床观察

目的:观察温脾消肿饮治疗特发性水肿的临床疗效。方法:以温阳健脾利水为治疗原则,用温脾消肿饮治疗特发性水肿患者39例,对照组服用氨苯喋啶片和谷维素片,均以30天为疗程。结果:治疗组的总体疗效和主要症状的改善显著优于西药对照组。结论:温脾消肿饮治疗特发性水肿具有较好临床应用前景,温阳健脾利水法可以作为中医治疗本病的主要治疗原则。     

"胃肠安"方治疗进展期胃癌的临床研究

目的：研究“胃肠安”方对胃癌术后患者生存率和肿瘤转移的作用。方法：采用前瞻性随机分组，将95例进展期胃癌根治术后患者分为中药组、中西医结合组和西药组进行治疗，观察3组患者的生存率及转移率。结果：中西医结合组的3年、5年生存率为75．9％、62．8％，高于西药组的52．8％、26．4％，差异有统计学意义（P〈0．05）。中药组、中西医结合组的5年转移率分别为27．78％、29．41％，明显低干西药组的56％，差异有统计学意义（P〈0．05）。中西医结合组和中药组的5年累计转移率没有显著性差异（P〉0．05）。结论：含“胃肠安”方的中西医结合治疗能显著提高胃癌术后患者的生存率；“胃肠安”方能显著降低胃癌术后转移率。     

草钟乳抗癌作用及流式细胞仪研究

对草钟乳进行了抗癌作用及流式细胞仪分析研究，结果表明：草钟乳对小鼠移植性肿瘤有明显的抑制作用，对Ｕ１４，ＥＡＣ，ＨｅＰＳ和Ｓ１８０的抑制率分别为４７．２５～５０．０２％，５８．１８％－５９．５６％，５０．９１－５２．１８％和５３．５３－５９．３８％，经流式细胞仪分析，认为本品作用于细胞增殖周期的Ｓ期，对Ｕ１４，ＥＡＣ，ＨｅＰＳ和Ｓ１８０的Ｓ期细胞的杀伤率分别为３９．８１％，３９．５１％，３１．７２